ATM and mantle cell lymphoma: Furthermore, the authors employed a murine xenograft model of an ATM-mutant mantle cell lymphoma cell line to demonstrate a significantly reduced lymphoma burden and an increased survival of animals following olaparib treatment in vivo (Weston et al., 2010).